Supplemental material
Scandinavian Journal of Urology
Volume 53, 2019 - Issue 5
Open access
2,372
Views
4
CrossRef citations to date
0
Altmetric
Articles
A registry-based study evaluating overall survival and treatment duration in Swedish patients with metastatic castration-resistant prostate cancer treated with enzalutamide
Mohammed AlghazaliDepartment of Urology, Skåne University Hospital, Malmö, Sweden; View further author information
, Annica LöfgrenDepartment of Urology, Skåne University Hospital, Malmö, Sweden; View further author information
, Leif JørgensenIQVIA Solutions a/s, Copenhagen, Denmark; View further author information
, Maja SvenssonAstellas Pharma a/s – Nordic Operation, Kastrup, DenmarkView further author information
, Karin FagerlundAstellas Pharma a/s – Nordic Operation, Kastrup, DenmarkView further author information
& Anders BjartellDepartment of Urology, Skåne University Hospital, Malmö, Sweden; Correspondence[email protected]
View further author information
View further author information
Pages 312-318
|
Received 29 Mar 2019, Accepted 15 Aug 2019, Published online: 06 Sep 2019
Related Research Data
A registry-based study evaluating overall survival and treatment duration in Swedish patients with metastatic castration-resistant prostate cancer treated with enzalutamide
Source:
Taylor & Francis
A registry-based study evaluating overall survival and treatment duration in Swedish patients with metastatic castration-resistant prostate cancer treated with enzalutamide
Source:
Taylor & Francis
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.